去BLASEing:1Q23财报季
1Q23利润同比大幅增长
1Q23 results beat and gradual recovery is likely
药明康德(603259)1Q23业绩电话会纪要-调研纪要
1Q23低起点,看好盈利逐季修复
1Q23 beat with sustainable profitability ahead
1Q23 dragged by higher investments and macro headwinds; Maintain BUY on 2H recovery
1Q23:净利润同环比大幅增长
1Q23业绩快速增长,巩固龙头地位
利息收入助1Q23业绩超预期,经营版图扩至马来西亚